Zydus Lifesciences Limited: Detailed financials
Line items extracted directly from the company's exchange-filed XBRL. Click + to expand subtotals. Click any row to chart it. Monetary values are in ₹ crore.
Company financials
| Particulars | Dec-24 | Mar-25 | Jun-25 | Sep-25 | Dec-25 | Mar-26 | Jun-26 | Sep-26 |
|---|---|---|---|---|---|---|---|---|
| 5,269 | 6,528 | 6,574 | 6,123 | 6,865 | 7,587 | 8,017 | 7,910 | |
| 58 | 81 | 155 | 109 | 111 | 134 | 106 | 130 | |
| 5,269 | 6,528 | 6,574 | 6,123 | 6,865 | 7,587 | 8,017 | 7,910 | |
| 4,143 | 4,717 | 4,808 | 4,511 | 5,538 | 5,664 | 6,798 | 6,807 | |
| 1,027 | 1,164 | 1,219 | 1,327 | 1,216 | 1,347 | 1,251 | 1,387 | |
| 571 | 573 | 658 | 589 | 852 | 972 | 1,289 | 1,260 | |
| −14 | −40 | −88 | −226 | −232 | −343 | −301 | −493 | |
| 947 | 971 | 1,005 | 1,034 | 1,140 | 1,239 | 1,368 | 1,357 | |
| 32 | 77 | 85 | 101 | 130 | 123 | 156 | 187 | |
| 229 | 238 | 238 | 302 | 360 | 508 | 555 | 605 | |
| 1,352 | 1,734 | 1,691 | 1,383 | 2,072 | 1,818 | 2,480 | 2,504 | |
| 1,445 | 1,987 | 2,243 | 2,091 | 1,843 | 2,291 | 2,017 | 2,026 | |
| 1,216 | 1,749 | 2,005 | 1,789 | 1,483 | 1,783 | 1,463 | 1,421 | |
| 1,184 | 1,892 | 1,921 | 1,722 | 1,438 | 2,057 | 1,325 | 1,233 | |
| — | −220 | — | −34 | −85 | −398 | −18 | 1 | |
| 1,184 | 1,672 | 1,921 | 1,687 | 1,353 | 1,660 | 1,307 | 1,234 | |
| 180 | 423 | 434 | 454 | 388 | 318 | 354 | 334 | |
| 1,026 | 1,244 | 1,521 | 1,239 | 1,023 | 1,341 | 990 | 928 | |
| Financial ratios | ||||||||
| 27.43% | 30.43% | 34.13% | 34.14% | 26.85% | 30.20% | 25.16% | 25.61% | |
| 19.48% | 19.05% | 23.14% | 20.23% | 14.90% | 17.67% | 12.35% | 11.73% | |
| 10.17 | 11.64 | 14.58 | 12.51 | 10.36 | 12.65 | 9.35 | 9.28 | |
Revenue
₹ crore
Select any table row to compare its reported history.
Source: official NSE or BSE financial-result filings & XBRL. Figures are exact values reported by the issuer at filing time, never estimated. Derived margins, subtotals, leverage and cash-flow measures use only the displayed filed line items.